STOK
Stoke Therapeutics Inc
NASDAQ: STOK · HEALTHCARE · BIOTECHNOLOGY
$32.42
-2.73% today
Updated 2026-04-29
Market cap
$1.92B
P/E ratio
—
P/S ratio
10.40x
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$8 – $40
Volume
0.8M
Stoke Therapeutics Inc (STOK) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-3.73%
Operating margin
-4,382.00%
ROE
-2.37%
ROA
-3.73%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-5.56M | — | — | — |
| 2018 | $0.00 | $-12.52M | — | — | — |
| 2019 | $0.00 | $-28.52M | — | — | — |
| 2020 | $0.00 | $-50.61M | — | — | — |
| 2021 | $3.00M | $-84.71M | -74.33% | -2,868.83% | -2,823.70% |
| 2022 | $12.40M | $-93.11M | 100.00% | -841.24% | -750.58% |
| 2023 | $8.78M | $-104.70M | 100.00% | -1,307.21% | -1,192.47% |
| 2024 | $36.55M | $-88.98M | 100.00% | -277.31% | -243.42% |
| 2025 | $184.42M | $-6.88M | 100.00% | -11.16% | -3.73% |